# Lantern Pharma (LTRN) — Earnings

LTRN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ltrn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.57 |
| EPS estimate | −$0.38 |
| EPS surprise | −50.00% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1763950/000149315226037971/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/f9b3a7d6-2423-f2c1-88c5-82b833dfb98c.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 14, 2026 | −$0.38 | −$0.57 | -50.00% | — | — |
| Q1 2026 | May 15, 2026 | −$0.36 | −$0.30 | 16.67% | — | — |
| Q4 2025 | Mar 30, 2026 | −$0.46 | −$0.36 | 21.74% | — | — |
| Q3 2025 | Nov 12, 2025 | −$0.47 | −$0.39 | 17.02% | — | — |
| Q2 2025 | Aug 13, 2025 | −$0.44 | −$0.40 | 9.09% | — | — |
| Q1 2025 | May 15, 2025 | −$0.49 | −$0.42 | 14.29% | — | — |
| Q4 2024 | Mar 27, 2025 | −$0.51 | −$0.54 | -5.88% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.56 | −$0.42 | 25.00% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.55 | −$0.46 | 16.36% | — | — |
| Q1 2024 | May 9, 2024 | −$0.43 | −$0.51 | -18.60% | — | — |
| Q4 2023 | Mar 18, 2024 | −$0.40 | −$0.39 | 2.50% | — | — |
| Q3 2023 | Nov 8, 2023 | −$0.48 | −$0.29 | 40.00% | — | — |
| Q2 2023 | Aug 9, 2023 | −$0.43 | −$0.44 | -1.55% | — | — |
| Q1 2023 | May 9, 2023 | −$0.48 | −$0.36 | 25.00% | — | — |
| Q4 2022 | Mar 20, 2023 | −$0.47 | −$0.31 | 34.04% | — | — |
| Q3 2022 | Nov 7, 2022 | −$0.48 | −$0.21 | 56.25% | — | — |
| Q2 2022 | Aug 8, 2022 | −$0.52 | −$0.41 | 21.15% | — | — |
| Q1 2022 | May 3, 2022 | −$0.29 | −$0.38 | -31.03% | — | — |
| Q4 2021 | Mar 10, 2022 | −$0.40 | −$0.31 | 23.13% | — | — |
| Q3 2021 | Nov 1, 2021 | −$0.27 | −$0.36 | -34.98% | — | — |

## Frequently Asked Questions

### When did Lantern Pharma (LTRN) last report earnings?

Lantern Pharma last reported on Aug 14, 2026, covering fiscal Q2 2026.

### Did LTRN beat earnings estimates?

No. Lantern Pharma reported EPS of −$0.57 for Q2 2026 against a −$0.38 estimate — a 50.00% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).